Caplin Point Laboratories Ltd.
Snapshot View

View in App

Prices View details >>

743.00 +14.05 ▲1.9%

30 September 2022, 11:43:59 AM
Volume: 135,800

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.caplinpoint.net
Market Cap 5,515.25 Cr.
Enterprise Value(EV) 5,080.80 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 41.42 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 17.57 Trailing Twelve Months Ending 2022-06
Industry PE 31.29 Trailing Twelve Months Ending 2022-06
Book Value / Share 196.13 Trailing Twelve Months Ending 2022-06
Price to Book Value 3.71 Calculated using Price: 727.60
Dividend Yield 0.55 Period Ending 2022-03
No. of Shares Subscribed 7.58 Cr. 75,800,542 Shares
FaceValue 2
Company Profile
Caplin Point is the mid-sized company in India's pharmaceutical sector to be engaged in the manufacture of APIs, finished formulations, research & development, clinical research, frontend generic presence in Latin America, brand marketing in Francophone Africa and an USFDA approved injectable facility.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.93%
1 Week
+3.55%
1 Month
-4.60%
3 Month
+4.59%
6 Month
+7.81%
1 Year
-15.97%
2 Year
+34.20%
5 Year
+7.56%
10 Year

Ratios View Details >>

9 years 2014-06 2015-06 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 53.24 55.78 43.13 54.97 49.43 37.14 29.58 25.65 24.71
Return on Capital Employed (%) 68.99 71.11 55.41 69.03 64.08 45.59 33.35 28.82 28.77
Return on Assets (%) 16.48 20.12 18.46 30.54 33.68 28.41 23.02 20.20 19.94

Balance Sheet View Details >>

Particulars 10 years 2013-06 Rs. Cr. 2014-06 Rs. Cr. 2015-06 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 43 62 93 128 225 364 633 948 1,186 1,484
Non Curr. Liab. 9 10 10 14 20 28 23 25 17 13
Curr. Liab. 83 108 125 125 113 109 86 144 143 208
Minority Int. 0 0 0 0 0 0 0 9 18 26
Equity & Liab. 135 180 229 267 358 500 743 1,126 1,364 1,730
Non Curr. Assets 96 131 147 149 179 196 249 303 349 432
Curr. Assets 39 49 82 119 179 304 494 823 1,015 1,298
Misc. Exp. not W/O
Total Assets 135 180 229 267 358 500 743 1,126 1,364 1,730

Profit Loss View Details >>

Particulars 10 years 2014-06 Rs. Cr. 2015-06 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 173 252 239 402 540 649 863 1,061 1,269 1,315
Other Income 4 3 4 10 13 19 41 28 39 43
Total Income 177 255 242 412 553 668 905 1,089 1,308 1,359
Total Expenditure -137 -192 -175 -277 -345 -417 -603 -737 -875 -911
PBIDT 40 63 68 135 208 251 301 352 433 448
Interest -1 -1 0 -1 -1 -1 0 -2 -1 0
Depreciation -4 -8 -7 -13 -19 -23 -32 -37 -47 -46
Taxation -10 -12 -14 -25 -44 -50 -54 -62 -77 -78
Exceptional Items
PAT 26 41 46 96 145 177 215 251 308 323
Minority Interest 0 0 0 0 0 -9 -9 -9
Share Associate
Other Related Items
Consolidated Net Profit 26 41 46 96 145 177 215 242 300 314
Adjusted EPS 3 5 6 13 19 23 28 32 40 41

Cash Flow View Details >>

Particulars 10 years 2013-06 Rs. Cr. 2014-06 Rs. Cr. 2015-06 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 32 60 50 42 68 66 83 45 269 337
Cash Fr. Inv. -45 -44 -23 -6 -36 -69 -100 -55 -29 -271
Cash Fr. Finan. -1 -6 -9 -14 -7 -12 90 80 -24 -41
Net Change -15 10 19 23 25 -14 73 70 215 25
Cash & Cash Eqvt 17 27 45 68 91 77 151 221 436 461

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 69.03 69.03 69.03 69.03 69.03 69.03 68.91 68.89 68.88
Public 30.97 30.97 30.97 30.97 30.97 30.97 31.09 31.11 31.12
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 29 Sep 2022
Annual General Meeting
Caplin Point Laboratories Limited has informed the Exchange about Proceedings of Annual General Meeting held on 29-Sep-2022
Tue, 13 Sep 2022
Loss of share certificate
Caplin Point Laboratories Limited has informed the Exchange about Loss of share certificate
Mon, 12 Sep 2022
Loss of share certificate
Caplin Point Laboratories Limited has informed the Exchange about Loss of share certificate

Technical Scans View Details >>

Thu, 29 Sep 2022
20 SMA Crossing 100 SMA From Above 20 SMA Crossing 100 SMA From Above
Wed, 28 Sep 2022
High Decrease 1 Month High Decrease 1 Month
Shooting Star Shooting Star
Gravestone Doji Gravestone Doji
Bearish Harami Cross Bearish Harami Cross

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 223,330.10 937.20 +0.7%
Divi's Laboratories Ltd. 97,819.86 3,682.65 -0.3%
Cipla Ltd. 90,339.79 1,112.35 -0.3%
Dr. Reddy's Laboratories Ltd. 72,565.89 4,307.85 -1.2%
Apollo Hospitals Enterprise Ltd. 63,143.03 4,397.75 +0.1%
Torrent Pharmaceuticals Ltd. 52,359.20 1,552.40 +0.4%
Abbott India Ltd. 40,610.60 19,250.00 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 57.42 937.20 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-06 31.50 3,682.65 -0.3%
Cipla Ltd. Consolidated 2022-06 36.30 1,112.35 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.26 4,307.85 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.47 4,397.75 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 65.37 1,552.40 +0.4%
Abbott India Ltd. Standalone 2022-06 50.22 19,250.00 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.46 937.20 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-06 7.87 3,682.65 -0.3%
Cipla Ltd. Consolidated 2022-06 4.20 1,112.35 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.58 4,307.85 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,397.75 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.19 1,552.40 +0.4%
Abbott India Ltd. Standalone 2022-06 13.62 19,250.00 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 937.20 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,682.65 -0.3%
Cipla Ltd. Consolidated 2022-03 0.04 1,112.35 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,307.85 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,397.75 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,552.40 +0.4%
Abbott India Ltd. Standalone 2022-03 0.00 19,250.00 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 937.20 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,682.65 -0.3%
Cipla Ltd. Consolidated 2022-03 13.10 1,112.35 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,307.85 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,397.75 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,552.40 +0.4%
Abbott India Ltd. Standalone 2022-03 29.95 19,250.00 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 937.20 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,682.65 -0.3%
Cipla Ltd. Consolidated 2022-03 13.10 1,112.35 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,307.85 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,397.75 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,552.40 +0.4%
Abbott India Ltd. Standalone 2022-03 29.95 19,250.00 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 937.20 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,682.65 -0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,112.35 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,307.85 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,397.75 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,552.40 +0.4%
Abbott India Ltd. Standalone 2022-03 4,919.27 19,250.00 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 937.20 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,682.65 -0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,112.35 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,307.85 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,397.75 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,552.40 +0.4%
Abbott India Ltd. Standalone 2022-03 798.70 19,250.00 +0.4%

FAQ's On Caplin Point Laboratories Ltd.

What is Caplin Point Lab share price?
Can I buy Caplin Point Lab shares now?
What is the Dividend Yield of Caplin Point Lab?
What is the Market Cap of Caplin Point Lab?
What are the key metrics to analyse Caplin Point Lab?
What is the 52 Week High and Low of Caplin Point Lab?
What is the trend of Caplin Point Lab share price?